Benjamin Korman is a Rheumatology/Immunology physician affiliated with University of Rochester Medical Center. OpenAlex indexes 66 publications with 4,142 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
125 Lattimore Rd Ste G-110
Rochester, NY 146204159
Telephone
585-486-0901Registry record last updated 29 Jun 2023.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
26.5%Proton pump inhibitor18.2%Pantoprazole Sodium31%Esomeprazole Magnesium30%Dexlansoprazole Dr21%Omeprazole18%Part D<11 patientsCorticosteroid8.3%Prednisone100%Part D≥16 patientsCancer & immunology
20.8%Folate Analog Metabolic Inhibitor10.7%Methotrexate100%Part D≥19 patientsInterleukin-6 Receptor Antagonist8%Actemra Actpen100%Part D<11 patients+ 1 more class in this area
Nervous system
16.4%Gabapentinoids6.8%Gabapentin100%Part D<11 patientsCholinergic Receptor Agonist5.5%Pilocarpine Hcl59%Cevimeline Hcl41%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment
University of Rochester
FY2026$480,269R01AR080015 - Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment
University of Rochester
FY2025$454,991R01AR080015 - Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment
University of Rochester
FY2024$496,637R01AR080015
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Louis Constine, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Edward Messing, MD
University of Rochester Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”